ZYXI - Zynex announces filing of patent for sepsis monitor

Medical technology company Zynex (ZYXI) has filed for a provisional patent for a noninvasive sepsis monitor for treating the life-threatening medical condition characterised by the body-wide inflammatory response or reaction that presents in response to infection.The signs and symptoms of sepsis often may be subtle. The low survival rate of patients with severe sepsis indicates that current sepsis identification strategies, tools, and methods may be lacking, the company said.Bacterial infections are the most common cause of sepsis, but sepsis can also be caused by fungal, parasitic, or viral infections.

For further details see:

Zynex announces filing of patent for sepsis monitor